Cargando…
DNA Methylation Predicts the Response of Triple-Negative Breast Cancers to All-Trans Retinoic Acid
All-trans retinoic acid (atRA) regulates gene expression and is used to treat acute promyelocytic leukemia. Attempts to use atRA in breast cancer without a stratification strategy have resulted in limited overall effectiveness. To identify biomarkers for the treatment of triple-negative breast cance...
Autores principales: | Coyle, Krysta Mila, Dean, Cheryl A., Thomas, Margaret Lois, Vidovic, Dejan, Giacomantonio, Carman A., Helyer, Lucy, Marcato, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266978/ https://www.ncbi.nlm.nih.gov/pubmed/30352973 http://dx.doi.org/10.3390/cancers10110397 |
Ejemplares similares
-
Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression
por: Coyle, Krysta Mila, et al.
Publicado: (2017) -
Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1
por: Coyle, Krysta M., et al.
Publicado: (2016) -
Abscopal responses in patients with metastatic melanoma involving skin and subcutaneous tissues treated with intralesional IL2 plus BCG
por: Vidovic, Dejan, et al.
Publicado: (2023) -
Cutaneous Breast Cancer Metastasis Is Effectively Treated With Intralesional Interleukin-2 and Imiquimod: A Case Report and Brief Literature Review
por: Drohan, Ashley, et al.
Publicado: (2022) -
ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells
por: Vidovic, Dejan, et al.
Publicado: (2019)